Search for a command to run...
Ticker: BFBIO • | Sector: PHARMACEUTICALS
RevRevenue
✓ GoodRs. 5.84 B
ProfitNet Profit
✓ GoodRs. 447.0 M
EPSEPS
₨5.52
ROEROE
~ Average9.6%
P/EP/E
✗ Bad21.0x
YieldDividend Yield
✗ Bad0.0%
BF Biosciences Limited has shown positive revenue growth of 59.5% over the past year. Net income has grown by 15.8% year-over-year. The company maintains a return on equity of 9.6%.
Company profile
BFBIO • PHARMACEUTICALS
BF Biosciences Limited ("BFBL", "Company", or the "Issuer") was incorporated as an unlisted public limited company under the Companies Ordinance, 1984 (now Companies Act, 2017) in 2006, and operates within the pharmaceutical industry. BFBL is a 80%:20% joint venture between Ferozsons Laboratories Limited and the Bagó Group of Argentina. The Company's core operations involve the import, manufacturing, marketing and distribution of pharmaceutical products.
BFBIO stock data provided by Ticker Analysts. Prices may be delayed. Data is for informational purposes only.